{"id":"W2122221221","doi":"10.1016/j.lungcan.2014.06.008","title":"Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma","year":2014,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pemetrexed; Medicine; Cisplatin; Mesothelioma; Internal medicine; Oncology; Chemotherapy; Clinical endpoint; Progression-free survival; Phases of clinical research; Performance status; Population; Randomized controlled trial; Gastroenterology; Urology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001351793,0.001774412,0.003289094,0.0004788157,0.0004985568,0.001381815,0.001342504,0.001543288,0.009322331],"category_scores_gemma":[0.00143243,0.0009493885,0.001747078,0.0005189523,0.00160459,0.001555016,0.000596312,0.004452728,0.001531889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001330861,"about_ca_system_score_gemma":0.001500225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00188081,"about_ca_topic_score_gemma":0.003674738,"domain_scores_codex":[0.9995071,0.0002414049,0.00002344495,0.0001114822,0.00002705522,0.00008947567],"domain_scores_gemma":[0.9993134,0.0001660687,0.0001088017,0.00007805761,0.00003445655,0.0002993356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9688516,0.007260509,0.0006003588,0.0005058622,0.0008392242,0.00004584428,0.00005319632,0.000716293,0.003708077,0.0001643205,0.00108384,0.01617082],"study_design_scores_gemma":[0.9484663,0.04877215,0.001128718,0.00001869968,0.0003574045,0.0000249168,0.00001979164,0.0002704421,0.0002863112,0.0001158178,0.0005294054,0.00001006703],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860805,0.0037023,0.0007463694,0.001320042,0.0007569768,0.003143429,0.001347816,0.0001521421,0.002750368],"genre_scores_gemma":[0.9868293,0.002233968,0.001231733,0.001263991,0.0003411456,0.002825228,0.001500362,0.00004191501,0.003732297],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009322331,"threshold_uncertainty_score":0.03118634,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008115870399044054,"score_gpt":0.2984022568962651,"score_spread":0.290286386497221,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}